Insmed Incorporated (INSM) Q3 2026 Earnings Call Transcript
Operator
Hello, everyone. Thank you for joining us, and welcome to the Insmed Third Quarter 2026 Financial Results Conference Call. [Operator Instructions] Please note that today’s call will include forward-looking statements. These statements represent the company’s judgment as of today and inherently involve risks and uncertainties that may cause actual results to differ materially from the projections discussed.
Please refer to Insmed’s most recent filings with the Securities and Exchange Commission for a full description of these risk factors. The information discussed on today’s call is meant for the benefit of the investment community. It is not intended for promotional purposes, and it is not sufficient for prescribing decisions.
Today’s call will feature prepared remarks about Insmed’s quarterly performance and financial position by Will Lewis, Chair and Chief Executive Officer; and Sara Bonstein, Chief Financial Officer, respectively. After their remarks, they will be joined by Martina Flammer, Chief Medical Officer, for the Q&A session.
I would now like to turn the call over to Will Lewis.
William Lewis
President, CEO & Chairman
Good morning. Today’s updates are intended to illustrate three overarching ideas. The first is that Insmed has evolved into a diversified biotechnology company that we
